Send me a link:

*Text messaging rates may apply.

 Dow Down 0.57% Nasdaq Down 0.83%

Celgene Corporation (CELG)

-NasdaqGS
86.53 Down 0.62(0.71%) 1:03PM EDT - Nasdaq Real Time Price
Prev Close:87.15
Open:86.85
Bid:86.38 x 200
Ask:86.40 x 200
1y Target Est:99.78
Beta:1.11
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:86.21 - 87.85
52wk Range:65.76 - 90.50
Volume:2,678,450
Avg Vol (3m):4,890,850
Market Cap:69.30B
P/E (ttm):27.54
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.71%69.30B
JNJDown 0.37%282.10B

Key Statistics

Forward P/E (1 yr):17.63
P/S (ttm):9.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback